# S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

> **NCT00003127** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 57 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** amifostine trihydrate
- **DRUG:** carboplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003127
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-02
- **Primary completion:** 2003-04
- **Final completion:** 2004-07
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2012-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003127, "S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*